[1]宋 丹,孙欣荣.模式识别受体的免疫调节作为限制流感策略研究进展[J].陕西医学杂志,2019,(3):401-403.
点击复制

模式识别受体的免疫调节作为限制流感策略研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年3期
页码:
401-403
栏目:
综述
出版日期:
2019-03-05

文章信息/Info

文章编号:
DOI:10.3969/j.issn.10007377.2019.03.032
作者:
宋 丹1; 孙欣荣
1．西安医学院（西安710068）；2.西安市儿童医院（西安710003）
关键词:
细胞; 受体; 模式识别; 免疫调节; 呼吸病毒感染
分类号:
R511.7
文献标志码:
A
摘要:
摘 要 细胞模式识别受体（PRR）是指种系编码的能够识别病原微生物的重要成分即病原相关分子模式，从而激活一系列信号通路，引发先天免疫反应的受体。已经开发出一些方法针对具体的PRR来刺激先天性免疫以减少各种疾病，包括流感感染。在这里，我们讨论免疫调节策略的进展，旨在针对先天免疫系统中的细胞相关PRR，以改变甲型流感病毒（IAV）感染的先天免疫反应或增加对流感疫苗的免疫反应。

参考文献/References:

[1] Janeway CA , Medzhitov R. Innate immune recognition [J] .Annu Rev Immunol, 2002, 20:197216.
[2] Akira S,Uematsu S,Takeuchi O.Pathogen recognition and innate immunity[J].Cell,2006,124(4):783801 \[3\] 闫鸿斌, 高闪电, 贾万忠, 等. 细胞内模式识别受体研究进展[J]. 免疫学杂志，2008，24(3): 359362. \[4\] 朱海峰, 王 亮. 细菌脂多糖作用下角膜上皮细胞Toll样受体2、4动态变化研究[J]. 陕西医学杂志,2015,44(3): 276278. \[5\] 余梦辰, 李 斌, 周 红. 内毒素识别、内化及清除相关受体的研究进展[J]. 重庆医学,2013,(29): 35643567.
[6] Ohnishi K,Komohara Y,Fujiwara Y,et al.Suppression of TLR4mediated inflammatory response by macrophage class A scavenger receptor(CD204)[J].Biochem Biophys Res Commun,2011,411(3):516522.
[7] Mukhopadhyay S,Varin A,Chen Y,et al.SRA/MARCOmediated ligand delivery enhances intracellular TLR and NLR function,but ligand scavenging from cell surface limits TLR4 response to pathogens[J].Blood,2011,117(4):13191328.
[8] Gauvreau GM, Hessel EM, Boulet LP,et al. Immunostimulatory sequences regulate interferoninducible genes but not allergic airway responses[J]. Am Respir Crit Care Med, 2006,174:1520.
[9] Pizzolla A, Smith JM, Brooks AG, et al. Pattern recognition receptor immunomodulation of innate immunity as a strategy to limit the impact of influenza virus[J]. Leukoc Biol,2017,101(4): 851861. 
[10] Behzad H, Huckriede AL, Haynes L,et al.GLASE, a synthetic tolllike receptor 4 agonist, enhances Tcell responses to influenza vaccine in older adults[J]. Infect Dis,2012, 205:466473.
[11] Hammerbeck DM, Burleson GR, Schuller CJ,et al . Administration of a dual tolllike receptor 7 and tolllike receptor 8agonist protects against influenza in rats[J]. Antiviral Res,2007,73:111.
[12] Wu CC, Crain B, Yao S, et al. Innate immune protection against infectious diseases by pulmonary administration of a phospholipidconjugated TLR7 ligand[J].Innate Immun,2014,6:315324.
[13] Lin L, Liu Q, Berube N, et al. 59Triphosphateshort interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIGI activation[J]. Virol,2012,86:1035910369.
[14] Lau YF, Tang LH, Ooi EE. A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic[J].Vaccine,2009,27:13541364.
[15] Tate MD, Ong JD, Dowling JK, et al. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition[J].Sci Rep,2016,6:27912.
[16] Robbins M, Judge A, MacLachlan I.siRNA and innate immunity[J]. Oligonucleotides,2009,19:89102.

相似文献/References:

[1]张晓燕,吴守振,刘春风,等.川崎病患者糖皮质激素受体、IL-17A、IL-6检测的临床意义[J].陕西医学杂志,2016,(10):1392.

更新日期/Last Update: 2019-03-15